LIPOPLUS

This brand name is authorized in Ecuador, Finland, Spain.

Active ingredients

The drug LIPOPLUS contains a combination of these active pharmaceutical ingredients (APIs):

1	Triglycerides, medium chain UNII C9H2L21V7U - MEDIUM-CHAIN TRIGLYCERIDES
	Read more about Triglycerides, medium chain
2	Soybean oil, refined UNII 241ATL177A - SOYBEAN OIL
	Read more about Soybean oil, refined
3	Omega-3-acid ethyl esters UNII 71M78END5S - OMEGA-3 FATTY ACIDS
	Read more about Omega-3-acid ethyl esters

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05BA	Solutions for parenteral nutrition	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions
Discover more medicines within B05BA
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	H4170413
ES	Centro de información online de medicamentos de la AEMPS	66708
FI	Lääkealan turvallisuus- ja kehittämiskeskus	020725